loader2
Partner With Us NRI

JFL Life Sciences Ltd

Company details

40.60
44.95
30.10
70.00
6M Return 0.00%
1Y Return -38.95%
Mkt Cap.(Cr) 44.65
Volume 6,000
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 6,000

Open Free Demat Account Online with ICICIDIRECT

FINANCIALS

Sales

Operating Profit

Profit after Tax

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after Tax

PE

Debt/Equity

P BV

COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 6.88 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 41.01 -16,297.57
LAST 3M 16,935.72 -4,368.10
LAST 6M 40,997.71 72,693.54
LAST 12M 176,172.92 -109,962.90

INFORMATION

Stock PE (TTM)

15.92

Promoter Holding

67.47%

Book Value

26.7822

ROCE

10.23%

ROE

8.82%

Description

  • JFL Life Sciences Ltd is a manufacturer of pharmaceutical products. The company, founded in 2010 under the name JFL Life Sciences Private Limited, has its registered office in Ahmedabad, Gujarat. The company had its initial public offering in 2022 and got certified with the name JFL Life Sciences Ltd. As of November 25, 2022, the company has a market capitalisation of Rs 43.72 crore. 

    In the last quarter of 2021, JFL Life Sciences Ltd earned Rs 25.63 crore in revenue and made a profit of Rs 2.53 crore after tax. The profit in the first quarter of 2021 was Rs 0.54 crore. 

    JFL Life Sciences Ltd. had its IPO between August 25 and August 30, 2022. The face value was Rs 10, the share price was Rs 61, and the lot size was 2,000 shares. The company was listed on the National Stock Exchange on September 8, 2022, with the ticker JFLLIFE.

    JFL Life Sciences Ltd. is a pharmaceutical company with an impressive line of products and manufacturing facilities. The company is active in India and 10 other developed and developing countries. JFL Life Sciences Ltd. engages in bulk sales of products to pharmaceutical marketers and traders, who in turn provide them with the channels to sell to the customers. The company does not sell under any specific brand name. Its product portfolio includes dry powder injections, tablets and capsules (B-Lactam) solid oral dosage form, tablets and capsules (General), and Oral Rehydration Solutions (ORS).

    Smiral Ashwinkumar Patel is the chairman and managing director of the company. Tejas Smiral Patel is the whole-time director, Manishkumar Jasavantlal Patel is the non-executive director, and Bhavna Shah is an independent director.  

    On November 25, 2022, JFL Life Sciences share price closed at Rs 39.75. The company’s share prices have gone down by 40.23% since its listing on the NSE on September 8, 2022. The peak share price was Rs 66.50, and the lowest was Rs 39. The share prices have gone down by 13.49% in the past month.  

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code:  56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

No Data Found

AGM Date (Month) :
Face Value Equity Shares : 10
Market Lot Equity Shares : 2000
BSE Code : 535469
NSE Code : JFLLIFE
Book Closure Date (Month) :
BSE Group :
ISIN : INE0LA901015

ICICIdirect JFL Life Sciences Ltd FAQ

You can buy JFL Life Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy JFL Life Sciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jan 25, 2023 03:43 PM the closing price of JFL Life Sciences Ltd was ₹ 40.60.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jan 25, 2023 03:43 PM, the market cap of JFL Life Sciences Ltd stood at ₹ 44.65.
The latest PE ratio of JFL Life Sciences Ltd as of Jan 25, 2023 03:43 PM is 15.92
The latest PB ratio of JFL Life Sciences Ltd as of Jan 25, 2023 03:43 PM is 0.66
The 52-week high of JFL Life Sciences Ltd is ₹ 70.00 while the 52-week low is ₹ 30.10

Download Our App

market app
market app